NasdaqCM - Delayed Quote USD

Semler Scientific, Inc. (SMLR)

25.91 -0.71 (-2.67%)
At close: April 25 at 4:00 PM EDT
Loading Chart for SMLR
DELL
  • Previous Close 26.62
  • Open 26.23
  • Bid 25.76 x 100
  • Ask 26.12 x 200
  • Day's Range 25.78 - 26.60
  • 52 Week Range 22.82 - 53.38
  • Volume 51,001
  • Avg. Volume 78,893
  • Market Cap (intraday) 182.175M
  • Beta (5Y Monthly) 0.89
  • PE Ratio (TTM) 9.85
  • EPS (TTM) 2.63
  • Earnings Date May 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

www.semlerscientific.com

92

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SMLR

Performance Overview: SMLR

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SMLR
41.50%
S&P 500
5.84%

1-Year Return

SMLR
6.60%
S&P 500
22.03%

3-Year Return

SMLR
76.66%
S&P 500
20.77%

5-Year Return

SMLR
41.75%
S&P 500
72.46%

Compare To: SMLR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SMLR

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    182.18M

  • Enterprise Value

    125.14M

  • Trailing P/E

    9.85

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.97

  • Price/Book (mrq)

    2.54

  • Enterprise Value/Revenue

    1.84

  • Enterprise Value/EBITDA

    5.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    30.19%

  • Return on Assets (ttm)

    20.42%

  • Return on Equity (ttm)

    32.29%

  • Revenue (ttm)

    68.18M

  • Net Income Avi to Common (ttm)

    20.58M

  • Diluted EPS (ttm)

    2.63

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    57.2M

  • Total Debt/Equity (mrq)

    0.23%

  • Levered Free Cash Flow (ttm)

    11.41M

Research Analysis: SMLR

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: SMLR

Fair Value

25.91 Current
 

Dividend Score

0 Low
SMLR
Sector Avg.
100 High
 

Hiring Score

0 Low
SMLR
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
SMLR
Sector Avg.
100 High
 

People Also Watch